|
ACHV
|
Achieve Life Sciences, Inc.
|
US
|
NASDAQ
|
|
ADAP
|
Adaptimmune Therapeutics plc
|
US
|
NASDAQ
|
|
AGEN
|
Agenus Inc.
|
US
|
NASDAQ
|
|
AVEO
|
AVEO Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
BCAB
|
BioAtla, Inc.
|
US
|
NASDAQ
|
|
CGEM
|
Cullinan Management, Inc.
|
US
|
NASDAQ
|
|
CLVS
|
Clovis Oncology, Inc.
|
US
|
NASDAQ
|
|
CNTA
|
Centessa Pharmaceuticals plc
|
US
|
NASDAQ
|
|
CRIS
|
Curis, Inc.
|
US
|
NASDAQ
|
|
EVAX
|
Evaxion Biotech A/S
|
US
|
NASDAQ
|
|
GMAB
|
Genmab A/S
|
US
|
NASDAQ
|
|
HCM
|
Hutchison China MediTech Limited
|
US
|
NASDAQ
|
|
IDRA
|
Idera Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
IMGN
|
ImmunoGen, Inc.
|
US
|
NASDAQ
|
|
INFI
|
Infinity Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
LCTX
|
Lineage Cell Therapeutics, Inc.
|
US
|
AMEX
|
|
LYEL
|
Lyell Immunopharma, Inc.
|
US
|
NASDAQ
|
|
MRTX
|
Mirati Therapeutics, Inc.
|
US
|
NASDAQ
|
|
NVCR
|
NovoCure Limited
|
US
|
NASDAQ
|
|
NXTC
|
NextCure, Inc.
|
US
|
NASDAQ
|